cAMP-mediated induction of cyclin E sensitizes growth-arrested adipose stem cells to DNA damage-induced apoptosis

Molecular Biology of the Cell

Volumn 19, Issue 12, 2008, Pages 5082-5092

  Ugland, Hege ^a   Boquest, Andrew C ^a   Naderi, Soheil ^a   Collas, Philippe ^a   Blomhoff, Heidi Kiil ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RETINOBLASTOMA PROTEIN;

ADIPOSE TISSUE CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GAMMA IRRADIATION; GENOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CYCLIC AMP; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; DNA DAMAGE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; NEURONS; ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN;

EID: 59449106021     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-01-0094     Document Type: Article

References (82)

1. Baksh, D., Song, L., and Tuan, R. S. (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell Mol. Med. 8, 301-316.
2. Bartek, J., Bartkova, J., and Lukas, J. (1996). The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805-814.
3. Berger, C., Pallavi, S. K., Prasad, M., Shashidhara, L. S., and Technau, G. M. (2005). A critical role for cyclin E in cell fate determination in the central nervous system of Drosophila melanogaster. Nat. Cell Biol. 7, 56-62.
4. Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., and Kaldis, P. (2003). Cdk2 knockout mice are viable. Curr. Biol. 13, 1775-1785.
5. Blomhoff H. K. et al. (1987). Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J. Cell. Physiol. 131, 426-433.
6. Bokemeyer D. et al. (2007). The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis. Nephrol. Dial. Transplant. 22, 3431-3441.
7. Boquest, A. C., Noer, A., and Collas, P. (2006a). Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev. 2, 319-329.
8. Boquest, A. C., Shahdadfar, A., Brinchmann, J. E., and Collas, P. (2006b). Isolation of stromal stem cells from human adipose tissue. Methods Mol. Biol. 325, 35-46.
9. Boquest, A. C., Shahdadfar, A., Fronsdal, K., Sigurjonsson, O., Tunheim, S. H., Collas, P., and Brinchmann, J. E. (2005). Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol. Biol. Cell 16, 1131-1141.
10. Bos, J. L. (2003). Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell Biol. 4, 733-738.
11. Burgering, B. M., Pronk, G. J., van Weeren, P. C., Chardin, P., and Bos, J. L. (1993). cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12, 4211-4220.
12. Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., and Sherr, C. J. (1999). The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
13. Clurman, B. E., Sheaff, R. J., Thress, K., Groudine, M., and Roberts, J. M. (1996). Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10, 1979-1990.
14. Daniel, P. B., Walker, W. H., and Habener, J. F. (1998). Cyclic AMP signaling and gene regulation. Annu. Rev. Nutr. 18, 353-383.
15. Deng, W., Obrocka, M., Fischer, I., and Prockop, D. J. (2001). In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Commun. 282, 148-152.
16. Dugan, L. L., Kim, J. S., Zhang, Y., Bart, R. D., Sun, Y., Holtzman, D. M., and Gutmann, D. H. (1999). Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J. Biol. Chem. 274, 25842-25848.
17. Dumaz, N., and Marais, R. (2005). Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 272, 3491-3504.
18. Geng Y. et al. (2007). Kinase-independent function of cyclin E. Mol. Cell 25, 127-139.
19. Geng Y. et al. (2003). Cyclin E ablation in the mouse. Cell 114, 431-443.
20. Gotoh, T., Shigemoto, N., and Kishimoto, T. (2007). Cyclin E2 is required for embryogenesis in Xenopus laevis. Dev. Biol. 310, 341-347.
21. Grewal, S. S., York, R. D., and Stork, P. J. (1999). Extracellular- signal-regulated kinase signalling in neurons. Curr. Opin. Neurobiol. 9, 544-553.
22. Guo, Y., Graham-Evans, B., and Broxmeyer, H. E. (2006). Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells. Stem Cells 24, 850-856.
23. Hong, Y., Cervantes, R. B., and Stambrook, P. J. (2006). DNA damage response and mutagenesis in mouse embryonic stem cells. Methods Mol. Biol. 329, 313-326.
24. Hwang, H. C., and Clurman, B. E. (2005). Cyclin E in normal and neoplastic cell cycles. Oncogene 24, 2776-2786.
25. Iacovelli, L., Capobianco, L., Salvatore, L., Sallese, M., D'Ancona, G. M., and De, B. A. (2001). Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol. Pharmacol. 60, 924-933.
26. Jackman, M., Kubota, Y., den, E. N., Hagting, A., and Pines, J. (2002). Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol. Biol. Cell 13, 1030-1045.
27. Jaiswal, R. K., Moodie, S. A., Wolfman, A., and Landreth, G. E. (1994). The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras. Mol. Cell Biol. 14, 6944-6953.
28. Jori, F. P., Napolitano, M. A., Melone, M. A., Cipollaro, M., Cascino, A., Altucci, L., Peluso, G., Giordano, A., and Galderisi, U. (2005). Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells. J. Cell. Biochem. 94, 645-655.
29. Kassem, M. (2004). Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 6, 369-374.
30. Kassem, M., Kristiansen, M., and Abdallah, B. M. (2004). Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin. Pharmacol. Toxicol. 95, 209-214.
31. Kim S. S. et al. (2005). cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. Neuroreport 16, 1357-1361.
32. Krebs, E. G., and Beavo, J. A. (1979). Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48, 923-959.
33. Le, C. L., Polanowska, J., Fabbrizio, E., Olivier, M., Philips, A., Ng, E. E., Classon, M., Geng, Y., and Sardet, C. (1999). Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J. 18, 1878-1890.
34. Leo, A. J., and Grande, D. A. (2006). Mesenchymal stem cells in tissue engineering. Cells Tissues. Organs 183, 112-122.
35. Leonce S. et al. (2001). Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. Mol. Pharmacol. 60, 1383-1391.
36. Lundberg, A. S., and Weinberg, R. A. (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell Biol. 18, 753-761.
37. Matsumoto, Y., and Maller, J. L. (2004). A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 306, 885-888.
38. Mazumder, S., DuPree, E. L., and Almasan, A. (2004). A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr. Cancer Drug Targets. 4, 65-75.
39. Mazumder, S., Gong, B., and Almasan, A. (2000). Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene 19, 2828-2835.
40. Mazumder, S., Gong, B., Chen, Q., Drazba, J. A., Buchsbaum, J. C., and Almasan, A. (2002). Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cells. Mol. Cell Biol. 22, 2398-2409.
41. Mazumder, S., Plesca, D., and Almasan, A. (2007). A Jekyll and hyde role of cyclin E in the genotoxic stress response: switching from cell cycle control to apoptosis regulation. Cell Cycle 6, 1437-1442.
42. McKnight, G. S. (1991). Cyclic AMP second messenger systems. Curr. Opin. Cell Biol. 3, 213-217.
43. Meloche, S., and Pouyssegur, J. (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26, 3227-3239.
44. Mimeault, M., and Batra, S. K. (2006). Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 24, 2319-2345.
45. Mittnacht, S. (1998). Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8, 21-27.
46. Mohapatra, S., Agrawal, D., and Pledger, W. J. (2001). p27Kip1 regulates T cell proliferation. J. Biol. Chem. 276, 21976-21983.
47. Morgan, D. O. (1997). Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291.
48. Moroy, T., and Geisen, C. (2004). Cyclin E. Int. J. Biochem. Cell Biol. 36, 1424-1439.
49. Mullany L. K. et al. (2007). Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J. Biol. Chem. 282, 21244-21252.
50. Naderi, S., Wang, J. Y., Chen, T. T., Gutzkow, K. B., and Blomhoff, H. K. (2005). cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21C:P1, and PCNA. Mol. Biol. Cell 16, 1527-1542.
51. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., and Roberts, J. M. (1994). Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
52. Ohtani, K., DeGregori, J., and Nevins, J. R. (1995). Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92, 12146-12150.
53. Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., and Pagano, M. (1995). Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol. 15, 2612-2624.
54. Oliva, A., Borriello, A., Zeppetelli, S., Di, F. A., Cortellazzi, P., Ventriglia, V., Criscuolo, M., Zappia, V., and Della, R. F. (2003). Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol. Cell Biochem. 247, 55-60.
55. Ortega, S., Prieto, I., Odajima, J., Martin, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., and Barbacid, M. (2003). Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35, 25-31.
56. Parisi, T., Beck, A. R., Rougier, N., McNeil, T., Lucian, L., Werb, Z., and Amati, B. (2003). Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 22, 4794-4803.
57. Regan, J. W. (2003). EP2 and EP4 prostanoid receptor signaling. Life Sci. 74, 143-153.
58. Rowinsky, E. K. (2005). Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J. Clin. Oncol. 23, 9394-9407.
59. Rozengurt, E., Legg, A., Strang, G., and Courtenay-Luck, N. (1981). Cyclic AMP: a mitogenic signal for Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 78, 4392-4396.
60. Rydel, R. E., and Greene, L. A. (1988). cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85, 1257-1261.
61. Schaffler, A., and Buchler, C. (2007). Concise review: adipose tissue-derived stromal cells- basic and clinical implications for novel cell-based therapies. Stem Cells 25, 818-827.
62. Seamon, K. B., and Daly, J. W. (1981). Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic. Nucleotide. Res. 7, 201-224.
63. Sevetson, B. R., Kong, X., and Lawrence, J. C., Jr. (1993). Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 90, 10305-10309.
64. Sherr, C. J. (1993). Mammalian G1 cyclins. Cell 73, 1059-1065.
65. Sherr, C. J. (1996). Cancer cell cycles. Science 274, 1672-1677.
66. Sherr, C. J., and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
67. Shi, G. X., Rehmann, H., and Andres, D. A. (2006). A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation. Mol. Cell. Biol. 26, 9136-9147.
68. Siegel, R. M. (2006). Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 6, 308-317.
69. Singer, J. D., Gurian-West, M., Clurman, B., and Roberts, J. M. (1999). Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13, 2375-2387.
70. Stork, P. J., and Schmitt, J. M. (2002). Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258-266.
71. Strickland, S., Smith, K. K., and Marotti, K. R. (1980). Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21, 347-355.
72. van den Heuvel, S., and Harlow, E. (1993). Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054.
73. Vossler, M. R., Yao, H., York, R. D., Pan, M. G., Rim, C. S., and Stork, P. J. (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89, 73-82.
74. Walsh, D. A., Perkins, J. P., and Krebs, E. G. (1968). An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle. J. Biol. Chem. 243, 3763-3765.
75. Wang, T. T., Tio, M., Lee, W., Beerheide, W., and Udolph, G. (2007). Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem. Biophys. Res. Commun. 357, 1021-1027.
76. Wang, Y., Maciejewski, B. S., Lee, N., Silbert, O., McKnight, N. L., Frangos, J. A., and Sanchez-Esteban, J. (2006). Strain-induced fetal type II epithelial cell differentiation is mediated via cAMP-PKA-dependent signaling pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L820-L827.
77. Weinberg, R. A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
78. Welcker, M., Singer, J., Loeb, K. R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B. E., and Roberts, J. M. (2003). Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12, 381-392.
79. Zarkowska, T., and Mittnacht, S. (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272, 12738-12746.
80. Zetterberg, A., Larsson, O., and Wiman, K. G. (1995). What is the restriction point? Curr. Opin. Cell Biol. 7, 835-842.
81. Zhao, L., Yang, S., Zhou, G. Q., Yang, J., Ji, D., Sabatakos, G., and Zhu, T. (2006). Downregulation of cAMP-dependent protein kinase inhibitor gamma is required for BMP-2-induced osteoblastic differentiation. Int. J. Biochem. Cell Biol. 38, 2064-2073.
82. Zuk P. A. et al. (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295.